Huakang Biomedical (08622) rose by more than 40% in intraday trading. As of press time, it rose by 31.63% to HKD 0.129, with a turnover of HKD 0.401 million.
According to the Wisdom Intelligence Financial App, Huakang Biomedical (08622) rose by more than 40% in intraday trading. As of press time, it rose by 31.63% to HKD 0.129, with a turnover of HKD 0.401 million.
On the news front, Huakang Biomedical announced that the Group plans to carry out enzyme-based product trade business involving online sales platforms and enterprises-to-enterprises product trade operation of Enzyme生活集团(China) Co., Ltd. Considering the sustained growth potential of enzyme-based products and e-commerce industries in domestic consumption in China in recent years, Directors believe that the new business venture will provide a good opportunity for the Group to diversify its sources of income, and ultimately improve the Group's financial performance.
